Laddar...
Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain
Mycobacterium tuberculosis, the etiological agent of tuberculosis (TB), infects over two billion people, claiming around 1.5 million lives annually. The only vaccine approved for clinical use against this disease is the Bacillus Calmette-Guérin (BCG) vaccine. Unfortunately, BCG has limited efficacy...
Sparad:
| I publikationen: | Vaccine |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4600678/ https://ncbi.nlm.nih.gov/pubmed/26363381 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2015.08.084 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|